Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.84 USD
+0.33 (3.47%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $9.88 +0.04 (0.41%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.84 USD
+0.33 (3.47%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $9.88 +0.04 (0.41%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth D Momentum A VGM
Zacks News
Teladoc Witnesses Higher Visits Due to Coronavirus Outbreak
by Zacks Equity Research
Teladoc's (TDOC) teleheath services are witnessing increase in demand due to coronavirus outbreak.
The Zacks Analyst Blog Highlights: HENKY, NFLX, PTON, TDOC and GILD
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HENKY, NFLX, PTON, TDOC and GILD
4 Sectors in Focus Following Coronavirus-Induced Selloff
by Urmimala Biswas
While COVID-19 has dealt a huge blow to most sectors, it has opened up enormous opportunities for a few.
Implied Volatility Surging for Teladoc Health (TDOC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Teladoc health (TDOC) stock based on the movements in the options market lately.
Teladoc (TDOC) Up 49% Year to Date: Will the Rally Continue?
by Zacks Equity Research
Teladoc (TDOC) benefits from its fast growing healthcare business and international expansion.
Can Telemedicine be a Market Savior on Rising Corona Scare?
by Urmimala Biswas
Here are four telemedicine stocks which have robust prospects to become attractive picks on the COVID-19 economic doldrums.
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FNY
Teladoc (TDOC) Hits New 52-Week High on Strong Q4 Results
by Zacks Equity Research
Teladoc (TDOC) reaches new 52-week high in the trading session on Feb 27 on impressive fourth-quarter results.
Teladoc (TDOC) Q4 Loss Narrower Than Expected, Revenues Beat
by Zacks Equity Research
Teladoc's (TDOC) Q4 results reflect strong revenue growth, partially offset by high expenses.
Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 21.21% and 1.76%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Teladoc's (TDOC) Q4 performance is likely to have benefited from increased membership and visits.
Molina Healthcare (MOH) to Post Q4 Earnings: What to Expect
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results are likely to reflect lower premium revenues and decline in medical membership.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $107.06 in the latest trading session, marking a -0.08% move from the prior day.
Cigna (CI) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) earnings performance is likely to have gained from the accretive Express Scripts acquisition.
Centene's (CNC) Q4 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) fourth-quarter results gain traction from better revenues.
What's in the Cards for Centene's (CNC) Earnings in Q4?
by Zacks Equity Research
Centene's (CNC) Q4 earnings results are likely to reflect membership growth and better revenues.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $104.75, moving +1.23% from the previous trading session.
Anthem's (ANTM) Q4 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results reflect solid revenues, partially offset by increased expenses.
HCA Healthcare (HCA) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q4 results gain traction from better revenues and increased admissions.
Anthem (ANTM) Gears Up for Q4 Earnings: What's in Store?
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results are likely to reflect a strong revenue stream.
What's in Store for HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q4 results are likely to reflect healthy growth in revenues and admissions.
Teladoc (TDOC) Hits 52-Week High: Will Momentum Sustain?
by Sapna Bagaria
Teladoc (TDOC) stock gains from from positive earnings pre-announcement and news to acquire InTouch Health.
Teladoc to Buy InTouch Health, Expand Reach in Virtual Care
by Zacks Equity Research
Teladoc (TDOC) to acquire InTouch Health and provide virtual health solutions ranging from critical to everyday care.
Teladoc Adds to its Services With Tailored Nutrition Plans
by Zacks Equity Research
Teladoc (TDOC) enhances its service portfolio with the addition of personalized diet programs.
Teladoc (TDOC) Up 73% Year to Date: Will the Rally Continue?
by Sapna Bagaria
Teladoc's (TDOC) presence in the growing telehealth industry with many deal wins and international expansion is likely to drive long-term growth.